WST
West Pharmaceutical Services Inc
361.80$
-0.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 68.5% | 67.4% | 66.8% | 67.9% | 68.2% | 67.0% | 64.2% | 58.5% | 60.5% | 61.6% | 65.4% | 64.1% | |
| 31.5% | 32.6% | 33.2% | 32.1% | 31.8% | 33.0% | 35.8% | 41.5% | 39.5% | 38.4% | 34.6% | 35.9% | |
| 2.6% | 2.4% | 2.4% | 2.4% | 2.3% | 2.1% | 2.2% | 1.9% | 2.0% | 2.3% | 2.4% | 2.4% | |
| 16.1% | 16.6% | 15.9% | 15.2% | 15.3% | 14.8% | 14.1% | 12.8% | 11.9% | 12.0% | 11.7% | 12.6% | |
| 18.7% | 19.1% | 18.3% | 17.6% | 17.0% | 16.9% | 16.3% | 14.7% | 13.0% | 14.3% | 14.1% | 15.8% | |
| 12.8% | 9.2% | 13.0% | 14.3% | 14.8% | 16.1% | 19.5% | 26.8% | 26.5% | 24.1% | 20.6% | 20.1% | |
| 0.9% | 0.9% | 0.5% | 0.4% | 0.5% | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% | 0.1% | 0.0% | |
| 11.9% | 8.3% | 12.6% | 13.9% | 14.5% | 16.3% | 19.5% | 27.2% | 24.3% | 24.3% | 20.7% | 20.0% | |
| 3.3% | 1.9% | 3.6% | 5.1% | 2.4% | 3.2% | 3.4% | 3.8% | 4.0% | 4.1% | 3.7% | 4.0% | |
| 8.9% | 6.8% | 9.5% | 9.4% | 12.0% | 13.1% | 16.1% | 23.4% | 20.3% | 20.1% | 17.0% | 16.1% | |
| 19.1% | 15.6% | 19.1% | 20.4% | 20.6% | 21.9% | 24.2% | 31.1% | 28.0% | 28.6% | 25.7% | 23.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.